• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

作者信息

Vergnes Jean-Noel

机构信息

Paul Sabatier University, Toulouse, France

出版信息

N Engl J Med. 2021 Apr 22;384(16):1577. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.

DOI:10.1056/NEJMc2036242
PMID:33596349
Abstract
摘要

相似文献

1
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA新冠疫苗的安全性和有效性
N Engl J Med. 2021 Apr 22;384(16):1577. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA新冠疫苗的安全性与有效性
N Engl J Med. 2021 Apr 22;384(16):1577-1578. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.
3
Safety and BNT162b2 mRNA COVID-19 vaccination.安全性和 BNT162b2 mRNA COVID-19 疫苗接种。
Acta Biomed. 2022 Jan 19;92(6):e2021485. doi: 10.23750/abm.v92i6.12359.
4
Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.BNT162b2 mRNA新冠疫苗的皮肤反应
Int J Dermatol. 2021 Jul;60(7):891-892. doi: 10.1111/ijd.15575. Epub 2021 Apr 14.
5
Anti-SARS-CoV-2 IgA Response in Baseline Seronegative and Seropositive Recipients of BNT162b2 mRNA COVID-19 Vaccine.BNT162b2 mRNA新冠疫苗基线血清阴性和血清阳性接种者中的抗SARS-CoV-2 IgA反应
J Occup Environ Med. 2021 Nov 1;63(11):e829. doi: 10.1097/JOM.0000000000002362.
6
Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?BNT162b2 mRNA新冠疫苗接种后眼睑出现紫癜性病变：SARS-CoV-2皮肤谜题的又一拼图？
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e543-e545. doi: 10.1111/jdv.17340. Epub 2021 May 28.
7
Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study.BNT162b2 mRNA新冠疫苗接种后引发的免疫性血栓性血小板减少症：一项病例研究
Thromb Res. 2021 Dec;208:1-3. doi: 10.1016/j.thromres.2021.10.002. Epub 2021 Oct 9.
8
Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration.BNT162B2 mRNA新冠疫苗接种后出现色素性紫癜性皮病
J Cosmet Dermatol. 2022 Feb;21(2):435-437. doi: 10.1111/jocd.14607. Epub 2021 Nov 17.
9
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.BNT162b2信使核糖核酸新冠疫苗诱发的冻疮样损伤强化了其与严重急性呼吸综合征冠状病毒2关系的假说。
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
10
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.6个月后对BNT162b2 mRNA新冠疫苗抗体反应的动态变化
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.

引用本文的文献

1
Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats.通过无针注射系统皮内递送严重急性呼吸综合征冠状病毒2（SARS-CoV-2）受体结合结构域3（RBD3）-Fc mRNA疫苗可在大鼠中诱导强烈的免疫反应。
Front Immunol. 2025 Feb 17;16:1530736. doi: 10.3389/fimmu.2025.1530736. eCollection 2025.
2
Polymeric nanocarriers for therapeutic gene delivery.用于治疗性基因递送的聚合物纳米载体。
Asian J Pharm Sci. 2025 Feb;20(1):101015. doi: 10.1016/j.ajps.2025.101015. Epub 2025 Jan 4.
3
Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion model.
在体外人胎盘小叶灌注模型中，靶向脂质纳米颗粒可防止经胎盘转运。
Drug Deliv Transl Res. 2025 Jun;15(6):1985-1993. doi: 10.1007/s13346-024-01715-6. Epub 2024 Oct 14.
4
Advances in Engineering Circular RNA Vaccines.工程化环状RNA疫苗的进展
Pathogens. 2024 Aug 15;13(8):692. doi: 10.3390/pathogens13080692.
5
The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in Macao.中成药及疫苗对新型冠状病毒肺炎患者的影响：一项在澳门开展的回顾性研究
Chin Med. 2024 Jan 23;19(1):15. doi: 10.1186/s13020-023-00877-8.
6
Mapping the intersection of nanotechnology and SARS-CoV-2/COVID-19: A bibliometric analysis.绘制纳米技术与SARS-CoV-2/新冠肺炎的交叉领域：一项文献计量分析。
Infect Med (Beijing). 2022 Jun;1(2):103-112. doi: 10.1016/j.imj.2022.06.005. Epub 2022 Jun 26.
7
Circular RNA vaccine in disease prevention and treatment.环状 RNA 疫苗在疾病防治中的应用。
Signal Transduct Target Ther. 2023 Sep 11;8(1):341. doi: 10.1038/s41392-023-01561-x.
8
Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel.接种和未接种医护人员的 SARS-CoV-2 症状、Ct 值和血清学反应之间的关系。
J Appl Lab Med. 2023 Sep 7;8(5):871-886. doi: 10.1093/jalm/jfad042.
9
CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2.CHO 细胞产生的 RBD-Fc 亚单位疫苗与不同佐剂联合使用可产生针对 SARS-CoV-2 的免疫应答。
PLoS One. 2023 Jul 14;18(7):e0288486. doi: 10.1371/journal.pone.0288486. eCollection 2023.
10
Status of and perspectives on COVID-19 vaccination after lifting of the dynamic zero-COVID policy in China.中国动态清零政策解除后新冠疫苗接种的现状与展望
Glob Health Med. 2023 Apr 30;5(2):112-117. doi: 10.35772/ghm.2022.01063.